Prusogliptin serves as a dipeptidyl peptidase-4 (DPP-4) inhibitor, functioning as an antidiabetic agent that helps manage type 2 diabetes by promoting insulin secretion while suppressing glucagon release.… Read more
Prusogliptin serves as a dipeptidyl peptidase-4 (DPP-4) inhibitor, functioning as an antidiabetic agent that helps manage type 2 diabetes by promoting insulin secretion while suppressing glucagon release. This category features high-quality reference standards essential for the rigorous analytical testing and quality control of this therapeutic compound. Laboratories utilize the included active pharmaceutical ingredient alongside a comprehensive range of impurities, such as process-related degradants and N-nitroso derivatives, to ensure accurate impurity profiling and method validation throughout the drug development lifecycle. Furthermore, the inclusion of stable isotope labelled compounds, such as deuterium-labelled analogues, provides critical internal standards for precise quantification in complex biological matrices via mass spectrometry. Accessing this precise collection of reference materials supports compliance with regulatory standards and facilitates the development of robust analytical methods required for pharmaceutical quality assurance.